InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,249.20
(
-0.05%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.96
(
-0.06%
)
Bitcoin
63,899.06
(
-1.42%
)
Post# of 514
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

califax

Send PM Follow Ignore
Followers 24
Posts 3015
Boards Moderated 0
Alias Born 01/18/2009

califax

Re: None

Friday, 02/10/2017 8:19:49 AM

Friday, February 10, 2017 8:19:49 AM

Post# of 514
Immunomedics to Receive $250 Million in Upfront Cash Payment; Plus Among Other Milestone Payments, an Additional $50 Million or Negotiated Economic Splits Relating to Rights Outside US, Canada and EU

http://ih.advfn.com/p.php?pid=nmona&article=73826688

http://ih.advfn.com/p.php?pid=nmona&article=73826913&symbol=IMMU

Immunomedics Enters into Exclusive Global Licensing Agreement with Seattle Genetics for Sacituzumab Govitecan (IMMU-132) with Potential Payments of up to Approximately $2 Billion, Plus Royalties

posts are IMHO // either news - with LINK

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up